Spots Global Cancer Trial Database for Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
Official Title: A Multi-Center Phase II Trial of Individualized Adaptive De-escalated Radiotherapy Using Pre and Mid-Treatment FDG-PET/CT for HPV-related Oropharynx Cancer
Study ID: NCT03416153
Conditions
Study Description
Brief Summary: This prospective study aims to utilize pre- and mid-treatment PET-CT to guide de-escalation of radiation therapy in HPV-related squamous cell carcinoma of the oropharynx.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Michigan Hospital, Ann Arbor, Michigan, United States
VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States
Contact Details
Name: Michelle Mierzwa, M.D.
Affiliation: University of Michigan Rogel Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
